Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/939
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMyers, Ken-
dc.contributor.otherJolley, Damien-
dc.date2008-11-
dc.date.accessioned2016-11-29T06:14:42Z-
dc.date.available2016-11-29T06:14:42Z-
dc.date.issued2009-02-
dc.identifier.citationEur J Vasc Endovasc Surg. 2009 Feb;37(2):239-45.en_US
dc.identifier.issn1078-5884en_US
dc.identifier.urihttp://hdl.handle.net/11434/939-
dc.description.abstractOBJECTIVE: To assess the efficacy of endovenous laser therapy (EVLT) for treating saphenous reflux associated with varicose veins. DESIGN: Out-patient treatment by EVLT with an 810nm laser wavelength with results assessed by ultrasound surveillance. PATIENTS: 361 patients who received EVLT for 509 incompetent saphenous veins over a five-year period. METHODS: EVLT was used for proximal saphenous veins and ultrasound-guided sclerotherapy (UGS) for distal saphenous veins and tributaries. Control of reflux and occlusion or obliteration of the saphenous veins was assessed by serial ultrasound studies. Univariate Kaplan-Meier life table analysis showed cumulative primary and secondary success rates, and multivariate Cox regression analysis assessed covariates that could be associated with increased risk of ultrasound failure. RESULTS: Life table analysis showed primary success at four years in 76% (95% CI 56-87%) and secondary success at four years after further treatment of recurrence by UGS in 97% (95% CI 93-99%). Cox regression analysis showed a non-significant trend towards worse primary success in male patients and worse results for older patients and limbs with clinical CEAP categories C4-6. Cox regression showed significantly worse secondary success for limbs with clinical CEAP C4-6. CONCLUSIONS: EVLT effectively controls saphenous reflux particularly with ultrasound surveillance to detect early recurrence that can be treated by UGS. Modifications in technique may be required to improve the late primary success rate.en_US
dc.publisherElsevieren_US
dc.relation.urihttp://www.sciencedirect.com/science/article/pii/S1078588409000057/pdfft?md5=0902c526ee235072ea3d5cdc6e77cf7c&pid=1-s2.0-S1078588409000057-main.pdf-
dc.subjectVaricose Veinsen_US
dc.subjectVenous Insufficiencyen_US
dc.subjectSaphenous Veinsen_US
dc.subjectSaphenous Refluxen_US
dc.subjectEndovenous Laser Therapyen_US
dc.subjectEVLTen_US
dc.subjectSclerotherapyen_US
dc.subjectUltrasounden_US
dc.subjectLaser Treatmenten_US
dc.subjectUltrasound-Guided Sclerotherapyen_US
dc.subjectUGSen_US
dc.subjectRecurrenceen_US
dc.subjectMultivariate Cox Regression Analysisen_US
dc.subjectUroRenal, Vascular Clinical Institute, Epworth HealthCare, Victoria, Australiaen_US
dc.titleOutcome of endovenous laser therapy for saphenous reflux and varicose veins: medium-term results assessed by ultrasound surveillance.en_US
dc.typeJournal Articleen_US
dc.identifier.doi10.1016/j.ejvs.2008.09.009en_US
dc.identifier.journaltitleEuropean Journal of Vascular and Endovascular Surgeryen_US
dc.description.pubmedurihttps://www.ncbi.nlm.nih.gov/pubmed/18993093en_US
dc.description.affiliatesMonash Institute of Health Services Research, Melbourne, Australiaen_US
dc.type.studyortrialRetrospective studiesen_US
dc.type.contenttypeTexten_US
Appears in Collections:Diagnostic Services
UroRenal, Vascular

Files in This Item:
File Description SizeFormat  
Myers.pdf341.69 kBAdobe PDFView/Open


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.